Followers | 13 |
Posts | 855 |
Boards Moderated | 0 |
Alias Born | 03/22/2022 |
Monday, October 23, 2023 1:01:25 PM
Good Job Moon Market your the real life Wolf of Wall Street
Still think the next catalysts will send it higher than under cash value unless the country implodes completely which looks like it isn't far away
GL
Recent PCSA News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:13:45 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/21/2024 08:10:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:16:05 PM
- Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference • GlobeNewswire Inc. • 03/28/2024 12:15:00 PM
- Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 03/25/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:13 PM
- Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference • GlobeNewswire Inc. • 02/21/2024 01:15:00 PM
- Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference • GlobeNewswire Inc. • 02/14/2024 06:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:30:35 PM
- Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule • GlobeNewswire Inc. • 02/06/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:32:03 PM
- Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering • GlobeNewswire Inc. • 02/01/2024 09:22:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:37:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 03:46:33 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 01/29/2024 09:15:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/29/2024 05:15:11 AM
- Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering • GlobeNewswire Inc. • 01/26/2024 02:04:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 01:35:27 PM
- Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses • GlobeNewswire Inc. • 01/25/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 01:00:12 PM
- Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer • GlobeNewswire Inc. • 01/19/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 01:30:13 PM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM